cently diagnosed diabetic mice (3 males and 3 females). These were killed within a week from the onset of diabetes as defined by the presence of glycosuria greater than 55 mmol/l for more than 1 week (measured by Diaburstix; Boehringer Mannheim, Mannheim, Germany). Furthermore, we studied 12 Balb/c mice, 6 males and 6 females at different ages (6, 20 and 40 weeks) and 12 NOR (non-obese resistant) mice (6 males and 6 females) at different ages: 8 weeks (1 male and 1 female), at 16 weeks (2 males and 2 females), at 24 weeks (2 males and 2 females).
The pancreas was removed, frozen in liquid nitrogen and stored at − 80°C until histological study was performed.
Histological analysis. Cryostat sections were prepared as follows: 4 consecutive 6 mm sections were cut and put on 4 different slides; approximately every 250 mm another 4 consecutive sections were cut and put on the slides, until each slide had 3 different sections thus allowing 10 to 30 islets of Langherans for each pancreas to be evaluated. One slide was used for CD95 immunostaining, the second one for CD95L, the third as negative control and the fourth was stained with haematoxylin-eosin. Sections were examined blindly by two different readers.
Immunoperoxidase staining. Sections for immunoperoxidase staining were fixed in fresh acetone for 30 min at room temperature. Endogenous biotin was blocked using a Streptavidin-Biotin blocking Kit (VECTOR sp-2001, Burlingame, Ca, USA). Then sections were stained with the following antibodies: biotinylated (Rat IgM) anti-mouse CD95L MoAb (Alexis 804-009B-T100, San Diego, Ca., USA) 1 : 50 in Tris Buffered Saline (TBS) with 10 % normal mouse serum and (rabbit) anti-mouse CD95 polyclonal antibody (Santa Cruz Biotechnology sc-716; In C, the section is stained to reveal the presence of CD95L and shows a typical ªcompleteº ring of CD95L positive cells in contrast with the ªnon-completeº ring shown in B. In D and E the same section shows the presence of CD95L (D) expressed only on glucagon containing cells (E). Only one glucagon containing cell can be detected as CD95L negative (arrow) Santa Cruz, Ca, USA) 1 : 500 in 10 % normal mouse serum. After 1 h incubation 30 ml of biotinilated rabbit anti-rat immunoglobulins (Dako E0468; Glostrup, Denmark, 1 : 300 TBS) or biotinilated goat anti-rabbit immunoglobulins (Dako E0432, Glostrup, Denmark 1 : 600 TBS) were added to the sections, respectively, and left for 60 min. The slides for negative control were stained only with the second antibodies. At the end of incubation all sections were treated with streptavidin ABC complex (Dako K0377) for 30 min and, after a 10 min incubation with diaminobenzidine substrate (1 mg/ml in Tris-HCI buffer), they were counterstained with Mayer's Haematoxylin. All antibodies were previously tested and titrated on Balb/c spleen (positive control for CD95) and testis sections (positive control for CD95L).
Following examination of CD95L expression in the islets of Langherans, we scored each islet as having a ªcompleteº or a ªnon-completeº ring of CD95L positive cells. We then calculated for each NOD mouse the percentage of islets with a ªcompleteº ring (Fig. 1) .
Immunofluorescence staining. For double immunofluorescence studies, other cryostat sections were cut, fixed in acetone for 30 min and stained as follows: alpha and beta cells were stained using a glucagon or insulin guinea pig anti-mouse antiserum (kindly donated by Dr. G. Cavallo) and revealed by 1 h incubation with a fluorescein isothiocyanate (FITC) conjugated rabbit anti-guinea pig polyclonal antibody (Sigma F7762; St. Louis, Mo, USA). The second staining was performed using a biotinylated CD95L anti-mouse MoAb (Rat IgM) revealed by 30 min incubation with Cy3-labelled-extravidin (Sigma, E4142). Before adding the CD95L MoAb, sections were incubated for 10 min with 10 % normal rat serum to avoid non-specific binding of the CD95L MoAb.
For double CD95 and glucagon or insulin staining we performed the following incubations: CD95 polyclonal antibody (1 h), biotinylated goat anti-rabbit immunoglobulins (30 min), Cy3-labelled-extravidin (30 min), 10 % normal rabbit serum (10 min), glucagon or insulin guinea pig antiserum (1 h), FITC conjugated rabbit anti-guinea pig polyclonal antibody (1 h).
Sections were then examined under an ultraviolet microscope using two different filters to visualize alternatively fluorescein (525 nm) and Cy3 (570 nm).
Morphological analysis of insulitis. The ªextent of insulitisº was evaluated and scored for each islet as previously described [1] . Briefly, islets were scored as 0 if no detectable lymphocytes were in the islet; 1) when few lymphocytes were around the islet (peri-insulitis); 2) if less than 50 % of islet area was infiltrated by lymphocytes; 3) if more than 50 % of islet area was infiltrated by lymphocytes. The score of the extent of insulitis was calculated for each pancreas.
Furthermore, the ªseverity of insulitisº was scored as the percentage of islets with a ªdestructiveº pattern. This was defined as the presence of mononuclear cells detectable inside the islet with loss of its architecture in contrast with the ªnon-destructiveº pattern, defined as a mononuclear cell infiltrate surrounding the islet without loss of its architecture.
Only islets with insulitis score of 2 or 3, where then scored for severity, since all peri-insulitis (extent score = 1) is non-destructive by definition. Approximately 3 % of islets were not considered for the ªseverityº score as they appeared with a borderline pattern.
Results
CD95 was not detected in Balb/c pancreas or in noninfiltrated NOD or NOR mouse islet cells. However, strong expression of CD95 appeared on mononuclear cells infiltrating the islets of NOD and NOR mice (Fig. 1 A) .
By contrast, CD95L was expressed on the endocrine pancreas of all mouse strains. Interestingly, positive cells were located in the periphery of islets forming a ring around them ( Fig. 1 B and C) . Only a few CD95L positive cells appeared in the middle of the islets. CD95L was undetectable on the mononuclear cells infiltrating the NOD and NOR islets.
Remarkably, double immunofluorescence studies revealed in all mouse strains that all CD95L positive cells were also positive for glucagon, indicating that they were alpha cells ( Fig. 1 D and E) .
Moreover, in NOD mice a ªcompleteº or a ªnon-completeº ring of CD95L positive alpha cells around beta cells correlated with a ªnon-destructiveº or ªde-structiveº insulitis pattern (Fig. 2) . No correlation was observed between the ªextentº of insulitis and the pattern of CD95L expression in the islets.
By contrast, insulin positive beta cells did not show detectable levels of CD95 or CD95L expression in any mice tested (data not shown).
Discussion
Here we show that pancreatic alpha cells of NOD, NOR and Balb/c mice constitutively express CD95L and that, within the limits of discrimination of immunohistochemical analysis, no quantitative difference in the expression was seen in the different strains of mice. The expression of CD95L on alpha cells might play opposing roles in the evolution of diabetes in NOD mice at different stages or under different microenvironmental conditions: a protective or an enhancing effect. As far as a possible protective role is concerned, the islets of Langerhans can be considered an immunologically priviledged tissue like the testis and the cornea [6, 7] . CD95L expression on alpha cells may act as a shield to protect beta cells from immunological attack. A similar protective effect on beta cells has been observed when CD95L expressing syngeneic myoblasts were co-transplanted with allogeneic islets in mice made diabetic with streptozotocin [8] . Nevertheless, the analysis of histological sections showed that in some islets mononuclear cells may have overcome this protection and penetrated the alpha-cell barrier (non-complete alpha-cell ring), resulting in a ªdestructiveº insulitis with beta-cell destruction. In other islets, mononuclear cells would not penetrate into the CD95L positive alpha-cell barrier (complete alpha-cell ring) and this would be morphologically characterized by a typical ªnon-destructiveº insulitis pattern, without destruction and loss of beta-cell mass.
On the other hand, CD95L expression on alpha cells might play a promoting role in the evolution of diabetes by contributing to beta-cell killing. It has been demonstrated that interleukin (IL)-1 beta induces CD95 expression in human thyrocytes and that co-expression of functional CD95 and CD95L in Hashimoto's thyroiditis may contribute to thyroid destruction [9] . CD95 expression has also been described on isolated human beta cells after IL-1 stimulation [10] . While we were unable to detect CD95 expression by immunostaining on murine beta cells it is possible that during IDDM progression in NOD mice CD95 expression is upregulated on beta cells to levels that make them sensitive to CD95L but which are too low to be detected by immunohistochemical staining, as also suggested by the results obtained in the CD95L transgenic mice [2] . If this is the case, CD95L positive alpha cells might be responsible for beta-cell destruction at some stage of the disease.
A better understanding of how mononuclear cells penetrate the alpha-cell barrier and how pancreatic alpha and beta cells interact, may provide new insights in clarifying the pathogenesis of IDDM.
